|
|||||
|
|
An open-label safety and efficacy study of an anti-CD20 antibody (rituximab,Rituxan) for anti-B-cell therapy in the treatment of systemic lupus erythematosus |
|
| Authors: | RA Eisenberg S Khan J Stansberry D Tsai S Kolasinski E Rieder B Kotzin RJ Looney C Strieber D Albert |
| Affiliation: | 1.Division of Rheumatology, Department of Medicine,University of Pennsylvania,Philadelphia,USA;2.Division of Hematology-Oncology, Department of Medicine,University of Pennsylvania,Philadelphia,USA;3.Division of Clinical Immunology, Department of Medicine,University of Colorado,Denver,USA;4.Division of Rheumatology, Department of Medicine,University of Rochester,New York,USA;5.Division of Rheumatology, Department of Medicine,University of Colorado,Denver,USA |
| Abstract: | |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |